Help improve human health. Prepare for a career researching and developing new clinical treatments such as vaccines and drug therapies, or take your skills into health policy or management.
You'll study advanced immunological theory and techniques and train in clinical trial design and practice. Develop your oral and written communication skills while you study and produce a research paper intended for publication.
The Master of Clinical Immunology (MClinIm) is taught in collaboration with the highly regarded Malaghan Institute of Medical Research, the largest private medical research institute in New Zealand. You'll also learn from practising clinicians from the local district health boards, the Medical Research Institute of New Zealand and other research institutions.
You'll complete your MClinIm in one calendar year over three trimesters.
You can choose to complete either your own research project or a work experience practicum. Both will give you the opportunity to be placed in a clinical or research environment to gain relevant experience. You might work or carry out research in a hospital, research institute or other medical organisation.
You'll graduate with the skills you need to assess, analyse and undertake clinical research in immunology in real-world settings.
In your first trimester you'll complete three core courses introducing you to clinical research, experimental trial design and clinical immunology. In the second trimester you'll study two more core courses and do your research project or practicum, or choose other elective courses.
If you achieve a B average or better, you'll be able to go on to study the two final courses in your last trimester. These will advance your clinical immunology knowledge and science communication skills, and you'll complete an individually mentored research proposal.
If you successfully complete the first part of the programme but for whatever reason are unable to complete the second, you may be awarded a Postgraduate Diploma in Biomedical Science.
If you are studying full time you can expect a workload of 40–45 hours a week for much of the year. It is possible to study part time, but you'll need to discuss this with the programme director. Part-time students doing one or two courses per trimester will need to do around 20–23 hours of work a week. Make sure you take this into account if you are working.
The MClinIm will prepare you for a range of senior roles in health research. You might work in a hospital, private research institute, diagnostic laboratory or pharmaceutical company, or for a government agency involved in health policy or delivery.
Our Medical Immunology courses offer you advanced training in basic and clinical immunology, including diagnostic technologies, laboratory management and research methodologies. The skills and knowledge you will develop with us are an ideal preparation for a laboratory-based career path.
Our course covers basic molecular and cellular immunology and the role of immunological mechanisms in auto-immune, systemic inflammatory, hypersensitivity, infective, immuno-deficiency and neoplastic disorders in which the immune system is involved. They also explore clinical transplantation, clinical immunology laboratory management and major laboratory techniques of diagnostic medical immunology.
The course will provide you with a broad-based expertise in immunology and an awareness of recent advances in the physiology of the immune system.
You may study this programme as an MSc, PG Diploma or PG Certificate. If you are a PG Certificate student, your programme can last either one or two years, depending on which modules you choose.
Whichever programme you are on, you will have one day of teaching a week through lectures. If you are an MSc or PG Dip student, we will expect you to undertake 10 hours of self-study a week; six hours if you are a PG Cert student.
Typically, one credit equates to 10 hours of work.
We will assess you through a combination of written and practical examinations and coursework. If you are an MSc or a PG Dip student taking the research project, you will also submit a research dissertation and have an oral exam in your second year.
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they are subject to change.
This course will allow you to develop your career in clinical, laboratory and academic immunology, for example running a diagnostic service, research group or clinical practice as a Clinical Scientist, Senior Lecturer/Professor or an NHS consultant.
Our Periodontology MClinDent combines academic study, clinical skills training and research and offers exceptional, innovative teaching. A wealth of academic expertise will give you a thorough practical education in advanced clinical periodontology, including aesthetics, implants and contemporary surgical methods.
The main themes which you will study are:
Through hands-on experience, you will acquire advanced competency in the full range of specialist periodontics clinical skills and complementary aspects of restorative dentistry.
Students will be exposed to research methods by seminars, extensive reviews of the classical and contemporary literature, critical appraisal of new scientific and clinical developments, and the completion of an in-depth literature review and a research project.
Our students have recently investigated smoking and periodontal health, periodontal microbiology and immunology, clinical trials of periodontal treatment and oral hygiene methods, behavioural factors in periodontology and periodontal relationships to systemic health.
You will achieve clinical proficiency in periodontics to a recognised UK specialist level and have the opportunity to sit a final conjoint membership examination with the Royal College of Surgeons of Edinburgh.
This course is available to study full-time over three years or over four years. The content is identical across both periods.
Designed to provide extensive contemporary knowledge and clinical proficiency in periodontology, qualified dentists train on this course to UK specialist level. The course has formal recognition for UK specialist training and offers greater depth of knowledge and clinical skills than is required for general practice.
The usual training period will be a minimum of 4,500 hours across the degree.
The course content is apportioned approximately as:
This time allocation is flexible and will depend upon the capacity of the trainees to complete the curriculum to a competent level.
Standard university term times do not apply to this course. You will receive a leave allowance for each academic year with full details provided on enrolment.
Your three academic taught modules will be assessed by written exams. Your six clinical modules will be examined on case reports, with oral and clinical examinations, and clinical examinations on unseen patients. Your research module will be assessed by a project report and oral examination.
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they may change if the course modules change.
Entry to the programme is strictly dependent upon occupational health clearance that you are able to conduct exposure prone procedures (EPPs) before you start clinical work. This will assess your hepatitis B surface antigen and hepatitis C antibody status, HIV and TB status following the completion of a health questionnaire and a further health check before or at enrolment.
If offered a place on the course, overseas students are advised to be tested locally and send the results of these checks with the questionnaire, prior to a separate full test in the UK at the College's Occupational Health Department before term begins. All offers of a place on a programme are made subject to a satisfactory criminal conviction disclosure. If you are from overseas or have never lived in the UK before, you should contact the relevant authorities in your home country to arrange for the equivalent check to be conducted and/or a certificate of good conduct to be issued.
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.